Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Guillén-Del-Castillo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Rheumatology|April 30, 2014
Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differencesC P Simeón-Aznar, C Tolosa-Vilella, L Gabarró-Juliá, et al.
Autoimmunity Reviews|July 15, 2018
Subclinical cardiovascular disease and Systemic Sclerosis: A comparison between risk charts, quantification of coronary calcium and carotid ultrasonographyI Sanz Pérez, F Martínez Valle, A Guillén-Del-Castillo, et al.
Autoimmunity Reviews|September 14, 2023
Immunoglobulins in systemic sclerosis management. A large multicenter experienceJ Tandaipan, A Guillén-Del-Castillo, C P Simeón-Aznar, et al.
Clinical Rheumatology|December 8, 2017
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio-Rivas, Xavier Corbella, Melany Pestaña-Fernández, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|April 30, 2014
Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differencesC P Simeón-Aznar, C Tolosa-Vilella, L Gabarró-Juliá, et al.
Autoimmunity Reviews|July 15, 2018
Subclinical cardiovascular disease and Systemic Sclerosis: A comparison between risk charts, quantification of coronary calcium and carotid ultrasonographyI Sanz Pérez, F Martínez Valle, A Guillén-Del-Castillo, et al.
Autoimmunity Reviews|September 14, 2023
Immunoglobulins in systemic sclerosis management. A large multicenter experienceJ Tandaipan, A Guillén-Del-Castillo, C P Simeón-Aznar, et al.
Clinical Rheumatology|December 8, 2017
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio-Rivas, Xavier Corbella, Melany Pestaña-Fernández, et al.
Pageof 1